This Is MS Multiple Sclerosis Knowledge & Support Community

Hollis-Eden reports promising results for multiple sclerosis treatment 14th September 2007 Hollis-Eden Pharmaceuticals has announced new data showing that its pre-clinical drug candidate provides benefit in an animal model of multiple sclerosis. The company is planning to present the results evaluat...

Here is the full article as posted in Annals of Neurology. It's interesting to see the effects on the various T-cells! Association between parasite infection and immune responses in multiple sclerosis Jorge Correale, MD *, Mauricio Farez, MD Department of Neurology, Raúl Carrea Institute for Neurolo...

As odd as it may sound there really might be something here! Below is an article about parasites and inflammartory bowel disease. If I had a choice between disablity or a parasite... give me the worm! Potential Disease Treatment: Swallow Some Worms By The Associated Press posted: 10 June 2006 10:39 ...

Here's a few more details on the study. I think I want a parasite! Parasite infection may benefit MS patients A steady rise in autoimmune diseases such as multiple sclerosis (MS) has been noted in recent decades, and environmental factors could be the cause of this increase. One theory, similar to t...

Stem Cell Therapy In Multiple Sclerosis - Now It Is Time To Really Start Main Category: Multiple Sclerosis News Article Date: 24 Nov 2006 - 0:00am (PST) Stem Cell Research Clinical research with human stem cells to repair brain damage in MS patients should be intensified. Although not unanimously, ...

From Medscape Neurology & Neurosurgery Expert Interview New Perspectives in Multiple Sclerosis: An Expert Interview With Mark S. Freedman, HBSc, MSc, MD Posted 11/01/2006 The 22nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) was held from September 27...

In fact, they also currently have a Phase I and Phase II recruiting for T-Cell Vaccine... I'm confused.

http://www.clinicaltrials.gov/ct/gui/sh ... A3?order=3

Interesting that it was confirmed in August of 2006 that they were still "currently recruiting patients". I wonder if the study has actually started yet! I hope it has.

Health Canada Grants Approval of TYSABRI(TM) (natalizumab) for the Treatment of Multiple Sclerosis Following Priority Review Wednesday October 4, 8:00 am ET First New Class of Treatment in Ten Years Shown to Reduce Rate of Relapses by 68%(1) MISSISSAUGA, Ontario & DUBLIN, Ireland--(BUSINESS WIRE)--...

Here's some more info about the study. High-Dose Cyclophosphamide Effective in Refractory Multiple Sclerosis CME News Author: Caroline Cassels CME Author: Désirée Lie, MD, MSEd August 25, 2006 — High-dose cyclophosphamide — a chemotherapeutic agent originally used to treat cancer — may offer patient...

You may be injecting too deep. What setting are you using for your legs? I dont have much fat on my legs so I use a setting of 4.

Lucky mice... again. Xanthus' Symadex Can Reverse Disease in Preclinical Multiple Sclerosis Animal Model Thursday September 28, 9:30 am ET - Results Presented at the 22nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis - CAMBRIDGE, Mass., Sept. 28 /PRNewswire/ -- ...

I guess I didn’t fully read your posting... you are only referring to the message board... and yes it appears they are shutting it down as of October. Sorry if I added to the confusion. Here's what I received in my messages: Dear MSWatch® member: Thank you for being a valued member of the MSWatch co...

Some info on testoserone and estrogen and their effects on the brain. Too much testosterone kills brain cells: study WASHINGTON (Reuters) - Too much testosterone can kill brain cells, researchers said on Tuesday in a finding that may help explain why steroid abuse can cause behavior changes like agg...

I had no problems login into my account. I had a message saying that they are in the process of modify their website... perhaps this caused the page to not be available for a short time? From what I can see, it's not shut down.